1. Brunel University Research Archive

Browsing by Author Gurgula, O

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 25  next >
Issue DateTitleAuthor(s)
23-Mar-2023Access Denied: the Role of Trade Secrets in Preventing Global Equitable Access to COVID-19 ToolsGurgula, O; McDonagh, L
15-Aug-2020AI-assisted inventions in the field of drug discovery: readjusting the inventive step analysisGurgula, O
12-Feb-2021Anti-competitive strategic patenting by pharmaceutical companiesGurgula, O
7-Feb-2018Anticompetitive Patent Acquisitions in the Pharmaceutical IndustryGurgula, O
1-Dec-2021Compulsory licensing of trade secrets: ensuring access to COVID-19 vaccines via involuntary technology transferGurgula, O; Hull, J
6-Jun-2021COVID-19, IP and access: Will the current system of medical innovation and access to medicines meet global expectations?Gurgula, O; Lee, WH
1-Jun-2021Drug prices, patents and access to life-saving medicines: changes are urgently needed in the COVID-19 eraGurgula, O
2023The interpretation of copyright protection in video game streaming in EuropeFarmaki, Despoina
23-Jan-2023The Intersection Between Intellectual Property and Competition Laws in the Pharmaceutical Sector: A Ukrainian PerspectiveGurgula, O
28-Sep-2017Monopoly v. Openness: Two sides of IP coin in the pharmaceutical industryGurgula, O
8-Oct-2020New anti-evergreening patent law in UkraineGurgula, O
27-Nov-2023The new EU compulsory licensing regime needs to allow the export of medicinesGurgula, O
22-Jan-2023The new IP Court in Ukraine: Its Creation and Exclusive JurisdictionShtefan, A; Gurgula, O
1-Feb-2024On the European Commission’s proposal to create a new EU-wide compulsory licensing regime.Gurgula, O
15-Nov-2016Patent Strategies and Competition Law in the Pharmaceutical Sector: Implications for Access to MedicinesGurgula, O; Matthews, D
2024Patenting Strategies by Pharmaceutical Companies: A Lawful Use of the Patent System or an Abusive Conduct?Gurgula, O
2020Response to the UK IPO ‘Open consultation: Artificial intelligence call for views: patents’Gurgula, O
2012Restrictive Practices in the Pharmaceutical Industry: Reverse Payment Agreements Seeking for a Balance between Intellectual Property and Competition LawGurgula, O
26-Jul-2022Saving Ukrainian lives during the russian war: Ukraine must waive IP rights under Article 73 TRIPS to provide access to essential medicinesGurgula, O
30-Dec-2021Specialised IP Judiciary: What Are the Key Elements to Consider when Establishing or Reforming an Effective IP Court?Gurgula, O; Padamczyk, M; Shemtov, N
Showing results 1 to 20 of 25  next >